Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections - Test2 - elhamkhani - TriplyDB

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

http://www.wikidata.org/entity/Q27485491

about

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates Animal models for Ebola and Marburg virus infections Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses Ebola haemorrhagic fever Ebola virus vaccines: an overview of current approaches Mouse models for filovirus infections Neglected filoviruses Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species Ebola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus "Filoviruses": a real pandemic threat?Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.A characterization of aerosolized Sudan virus infection in African green monkeys, cynomolgus macaques, and rhesus macaques Towards broad protection against Ebolaviruses.Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.Bioinformatics in new generation flavivirus vaccines.A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge.Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.DNA vaccines for biodefense.Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.Immune memory to Sudan virus: comparison between two separate disease outbreaks.Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.Clinical aspects of Marburg hemorrhagic fever Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections Filovirus vaccines.A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice Cysteine Cathepsin Inhibitors as Anti-Ebola Agents.Prospects for immunisation against Marburg and Ebola viruses.Progress in filovirus vaccine development: evaluating the potential for clinical use.Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges

P2860

Q21090120-06F0D12C-47EB-47D8-B5C0-67742C6A7CC4 Q21131118-195C9A4B-2A36-45F3-875C-1ABEC945D4F2 Q21131585-4B2DC747-0BFD-43E3-9111-1751BF6FFE69 Q21562420-540565A9-1844-4A9E-A190-0972BD4A1F3A Q24629338-14A3A53F-9993-4792-9449-0BC99D7CC780 Q26999232-08592537-AD1B-46DD-BA27-BBCEC96EB446 Q27011569-CA245068-313A-479C-8C13-312864C85FAD Q28383265-54C13084-AA26-4E21-A3A7-59D33C20086C Q28485505-A7FF2B32-E9E0-46B0-90E6-BB425699F9FF Q30234637-D12EC3FF-D24C-4D49-BFF1-03C3D32E5D94 Q30235073-3AF2BDBC-466F-4D30-A30D-BBCEA8A28ED5 Q30384090-F5B5116A-FD01-49E7-B531-B42E75F1B3DB Q30724121-F367EAAB-42D0-46EF-B6AC-E54235FF0729 Q31152190-1CF24076-D5BD-4EEF-BC99-E925FF4386DE Q33404642-05AC3996-9BEB-473F-A7DC-40F531499C3D Q33745567-E5A4CEDC-6CF1-40A7-9DC7-45761BBA27B8 Q33768646-6FDD4DAB-A0DA-47B6-A15B-BEE7E9142198 Q33825309-844FAB78-42EF-48BC-8EDD-1099C850F9FB Q33839001-9F6CFF65-C6ED-4771-9104-118B27BCCBB7 Q34029668-8916822C-0353-4B8F-9E5F-2088D7380B47 Q34120895-E4ECBD4B-C9B3-4023-A6C9-7F21778BBC66 Q34465812-C600D3E9-1992-4885-858C-808E22810B50 Q34598925-FE858486-8E0D-480B-869F-19CE9D68485C Q34606818-FC11B1BF-013F-4CCD-B24D-B0DF19EA6BBF Q34614260-86EC9991-F7F3-4D06-9F9B-5DE413946C8F Q34632946-AD8944BC-3031-4C81-8E4A-0EE611C1BD6E Q34703785-22AC9397-8471-46D1-86C7-4C3A311F81BB Q34774783-C9702F84-0373-4C93-BFA7-F33A14E98D4E Q35014908-0419B7C2-6BA3-49F6-82A9-416C9CEF523E Q35048254-96032A02-291A-4462-8CBD-7D9D67EE9B1F Q35300062-FA7BF547-AB7C-4DED-9ECE-BA94C65CCB04 Q35446144-1FF5E9B0-7185-4740-86E1-A94FAA497462 Q35557184-4916B7A3-44A8-4220-B800-DAF973A81622 Q35558539-6DF02DB5-D636-48F1-952E-1A2D03FF391E Q35798489-D827A6BF-AD70-48BC-ACD3-A9087BF798D3 Q36043238-45793DC3-FA6F-4FB1-8172-8C0F05F31226 Q36062150-4EA731D4-25F1-4617-A1CC-4BAD500D3148 Q36088118-3C62E4B3-D290-4F05-9A4B-E8D62251FDD0 Q36100545-4596FE91-642D-4DE9-9221-4D7F41839925 Q36255716-0FB7B4E7-CCFE-430C-AE3A-BA0630B63B59

P2860

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

http://www.wikidata.org/entity/Q27485491

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@ast

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@en

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@nl

type

label

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@ast

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@en

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@nl

prefLabel

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@ast

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@en

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@nl

P1433

Q27485491-91F29891-E89C-4179-A8E6-FA769E673FCA

P1476

Q27485491-9A91B3E9-125C-4DD5-827C-F1E08C7CEC3E

P2093

Q27485491-40A807D9-57A1-47F3-B000-540472FB7E7A

Q27485491-4859C992-11F2-41F9-92E5-CCED19FABC0D

Q27485491-4B711B89-F176-48E8-8F20-F5BAAA68BB30

Q27485491-8BAC814D-E4A6-461E-AF25-DBE5EF509137

Q27485491-8CFF71CD-D714-4D8C-9A60-589E907874F4

Q27485491-8DC520DD-07C1-43F9-98CC-0C6ECE3D1BBB

Q27485491-A9643AE9-B318-4564-86AA-F1330BFBD282

Q27485491-EA301E53-1862-484A-8626-D271F2FD8A53

P2860

Q27485491-081329A7-AD9B-4382-A684-FD15F949069B

Q27485491-0CD4C826-49E6-477F-8107-35F4BEB3B7C0

Q27485491-157F4548-20E6-4A89-9238-EE3D9B15C60E

Q27485491-17811ACF-B441-47C1-A40B-C324FF82CF8A

Q27485491-1824B86F-AD99-48AD-94BE-23C12FA8991F

Q27485491-2985C0B9-926E-46A5-AABF-44817C1FC315

Q27485491-31F9654F-0261-4F84-A9DC-ECD807FD42EE

Q27485491-34612AEB-74B6-484D-B1F7-E420B325A241

Q27485491-397746E6-1974-4000-B4E4-3664E139E206

Q27485491-44BA01BC-D045-44FC-B5ED-ABBD5586DBE4

P304

Q27485491-2064E68C-B159-42D1-8F23-7281B25BC742

P31

Q27485491-01D9CDCE-883E-4D69-A77F-15E9B9821B28

P3181

Q27485491-F819E9B9-8CAF-4F72-A5A4-40971015AA53

P356

Q27485491-48D40A9A-BE2D-468F-B7F0-FB7FAB966EB0

P433

Q27485491-72BBF213-B91A-4B25-A3C7-3F679FBE81BC

P478

Q27485491-803725AB-534E-442E-842D-3C14C35E89E4

P577

Q27485491-1786D942-F48F-4F8B-96D3-D509D8777408

P698

Q27485491-747FC6E2-8E6D-47E4-B9F8-9F7DA4E2501A

P921

Q27485491-429B540C-F2FC-4209-81BD-B9F8A80D9928

Q27485491-8C7B44CA-6305-4185-AFAC-22B91728EF9B

Q27485491-C967F55B-A025-4306-8247-321687E81CA9

Q27485491-E2793128-1D16-4EE2-840A-938E9D3CBB5C

Q27485491-E97B4B41-4F1B-497A-BF14-F540F8AA55B7

Q27485491-F8A64DDE-33D1-4682-9A08-1133215EE3ED

P932

Q27485491-66477CD3-8C5F-46B2-8FD7-274604B4389E

P3181

P356

P1433

Clinical and Vaccine Immunology

P1476

Vaccine To Confer to Nonhuman ...... a and Marburg Virus Infections

@en

P2093

Dana L Swenson

http://www.w3.org/2001/XMLSchema#string

Danher Wang

http://www.w3.org/2001/XMLSchema#string

David H Holman

http://www.w3.org/2001/XMLSchema#string

Jan Woraratanadharm

http://www.w3.org/2001/XMLSchema#string

John Y Dong

http://www.w3.org/2001/XMLSchema#string

Kelly L Warfield

http://www.w3.org/2001/XMLSchema#string

Min Luo

http://www.w3.org/2001/XMLSchema#string

William D Pratt

http://www.w3.org/2001/XMLSchema#string

P2860

Effective post-exposure treatment of Ebola infection

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.

Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes

Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.

Development of a preventive vaccine for Ebola virus infection in primates

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

Marburg hemorrhagic fever in Angola--fighting fear and a lethal pathogen.

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

Immune responses to adenovirus and adeno-associated virus in humans.

Marburg and Ebola viruses as aerosol threats.

P304

460-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1713194

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/CVI.00431-07

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18216185

http://www.w3.org/2001/XMLSchema#string

P921

Vaccine against Ebola

Marburg marburgvirus

clinical chemistry

P932

2268273

http://www.w3.org/2001/XMLSchema#string